Intravenous magnesium for the treatment of cardiac arrhythmias

Australian and New Zealand Journal of Medicine

Volumn 30, Issue 1, 2000, Pages 54-60

  Arnold, D J ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; DIGITALIS; DIGOXIN; GLUCONATE CALCIUM; MAGNESIUM SULFATE;

ANTIARRHYTHMIC ACTIVITY; CLINICAL TRIAL; DIGITALIS INTOXICATION; DRUG INDICATION; DRUG MECHANISM; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERMAGNESEMIA; MAGNESIUM BLOOD LEVEL; MUSCLE WEAKNESS; NAUSEA; PRACTICE GUIDELINE; QT INTERVAL; REENTRY TACHYCARDIA; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES; VOMITING;

EID: 0034117940     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2000.tb01055.x     Document Type: Review

References (46)

1. 1. McLean RM. Magnesium and its therapeutic uses: A review. Am J Med 1994; 96: 63-76.
2. 2. Frakes MA, Richardson LE. Magnesium sulfate in certain emergency conditions. Am J Emerg Med 1997; 15: 182-7.
3. 3. Fazekas T, Scherlag BJ, Vos M, Wellens HJ, Lazzara R. Magnesium and the heart: antiarrhythmic therapy with magnesium. Clin Cardiol 1993; 16: 768-74.
4. 4. Wester PO. Magnesium effect on arrhythmias (Editorial). Int J Cardiol 1986; 12: 181-3.
5. 5. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker (Editorial). Am Heart J 1984; 108: 188-93.
6. 6. Levine BS, Coburn JW. Magnesium the mimic/antagonist of calcium (Editorial). N Engl J Med 1984; 310: 1253-5.
7. 7. Kulick DL, Hong R, Ryzen E et al. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J 1988; 115: 367-73.
8. 8. Davidenko JM, Cohen L, Goodrow R, Antzelevitch C. Quinidine induced action potential prolongation, early after depolarization, and triggered activity in canine purkinje fibers. Effects of stimulation rate, potassium and magnesium. Circulation 1989; 79: 674-86.
9. 9. Baile DS, Inoue H, Kaseda S et al. Magnesium suppression of early after depolarizations and ventricular tachycardias induced by caesium in dogs. Circulation 1988; 77: 1395-402.
10. 10. Smith WM, Gallagher JJ. 'Les torsades de pointes' An unusual ventricular arrhythmia. Ann Intern Med 1980; 93: 578.
11. 11. Soffer J, Dreifus LS, Michelson EL. Polymorphous ventricular tachycardia associated with normal and long QT intervals. Am J Cardiol 1982; 49: 2021.
12. 12. Perticone F, Adinolfi L, Bonaduce D. Efficacy of magnesium sulfate in the treatment of torsade de pointes. Am Heart J 1986; 112: 847-9.
13. 13. Keren A, Tzivoni D, Benhorin J, Gottlieb S, Stern S. Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients. Circulation 1981; 64: 1167.
14. 14. Keren A, Tzivoni D, Golhmann J, Benhorin J, Stern S. Ventricular pacing in atypical ventricular tachycardia. J Electrocardiol 1981; 14: 201.
15. 15. Tzivoni D, Keren A, Cohen AM, Stern S. Magnesium therapy for torsades de pointes. Am J Cardiol 1984; 53: 528.
16. 16. Tzivoni D, Banai S, Schuger C et al. Treatment of torsades de pointes with magnesium sulfate. Circulation 1988; 77: 392-7.
17. 17. Toivonen LK, Leinonen H. Limited effect of magnesium sulfate on torsades de pointes ventricular tachycardia. Int J Cardiol 1986; 12: 260-2.
18. 18. Emergency cardiac care committee and subcommittees AHA. Guidelines for cardiopulmonary resuscitation and emergency cardiac care - part III: adult advanced cardiac life support. JAMA 1992; 268: 2171-302.
19. 19. Tzivoni D, Keren A. Suppression of ventricular arrhythmias by magnesium. Am J Cardiol 1990; 65: 1397-9.
20. 20. Wesley RC, Haines DE, Lerman BB, Di Mario JP, Crampton RS. Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol 1989; 63: 1129-31.
21. 21. Sager PT, Widerhorn J, Peterson R et al. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with re-entrant AV supraventricular tachycardia. Am Heart J 1990; 119: 308-16.
22. 22. Visken S, Belhassen B, Sheps D, Laniado S. Clinical and electrophysiological effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate. Am J Cardiol 1992; 70: 879-85.
23. 23. Gullestad L, Birkeland K, Molstad P et al. The effect of magnesium versus verapamil on supraventricular arrhythmias. Clin Cardiol 1993; 16: 429-34.
24. 24. Leduc TJ, Carr JD. Magnesium sulfate for conversion of supraventricular tachycardia refractory to intravenous adenosine. Ann Emerg Med 1996; 27: 375-8.
25. 25. Iseri LT, Fairshler RD, Hardeman JL, Brodsky MA. Magnesium and potasssium therapy in multifocal atrial tachycardia. Am Heart J 1985; 110: 789-94.
26. 26. Iseri LT, Allen BJ, Brodsky MA. Magnesium therapy of cardiac arrhythmias in critical care medicine. Magnesium 1989; 8: 299-306.
27. 27. Brodsky MA, Orlov MV, Capparelli EV et al. Magnesium therapy in new onset atrial fibrillation. Am J Cardiol 1994; 73: 1227-9.
28. 28. Falk RH, Knowlton AA, Bernard SA, Gotleib NE, Battinelli NJ. Digoxin for converting recent onset atrial fibrillation to sinus rhythm: a randomised double blind trial. Ann Intern Med 1987; 106: 503-6.
29. 29. Moran J, Gallagher J, Peake S, Cunningham DN, Salagaras M, Leppard P. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomised study. Crit Care Med 1995; 23: 1816-24.
30. 30. Iseri LT, Allen BJ, Ginkel ML et al. Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium. Am Heart J 1992; 123: 1404-9.
31. 31. Allen BJ, Brodsky MA, Capparelli EV et al. Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia. Am J Cardiol 1989; 15: 1202-4.
32. 32. Brooks R, McGovern BA, Brussel T et al. Limited effectiveness of magnesium infusions for suppressing inducible sustained monomorphic ventricular tachycardia (Abstr.). Circulation 1989; 80: II-659.
33. 33. Tzivoni D, Keren A, Stern S. Torsades de pointes versus polymorphous ventricular tachycardia (Editorial). Am J Cardiol 1983; 52: 639.
34. 34. Kay GN, Plumb VS, Arciniegas JG et al. Torsades de pointes: The long-short initiating sequence and other clinical features. Observations in 32 patients. J Am Coll Cardiol 1983; 2: 806.
35. 35. Mazhar MK, Kathleen RL, Janet MM, Jennifer A. Management of recurrent ventricular tachyarrhythmias associated with QT prolongation. Am J Cardiol 1981; 47: 1301.
36. 36. Tobey RC, Birnbaum GA, Allegra JR et al. Successful resuscitation and neurologic recovery from refractory ventricular fibrillation after magnesium sulfate administration. Ann Emerg Med 1992; 21: 92-6.
37. 37. Craddock L, Miller B, Clifton G et al. Resuscitation from prolonged cardiac arrest with high dose intravenous magnesium sulfate. J Emerg Med 1991; 9: 469-76.
38. 38. Thel MC, Armstrong AL, McNulty S et al. Randomised trial of magnesium in in-hospital cardiac arrest. Lancet 1997; 350: 1270-6.
39. 39. Jaffe AS. The use of antiarrhythmics in advanced cardiac life support. Ann Emerg Med 1993; 22: 307-16.
40. 40. Jackman WM, Friday KJ, Anderson JL et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988; 31: 115-72.
41. 41. French JH, Thomas RG, Siskind AP, Iseri LT. Magnesium therapy in massive digoxin intoxication. Am J Emerg Med 1984; 13: 562-6.
42. 42. Zwillinger L. Uber die magnesiumwirkung auf das Herz. Klin Wochenscher 1935; 14: 1429-33.
43. 43. Kinlay S, Buckley NA. Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity. Clin Toxicol 1995; 13: 55-9.
44. 44. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. A randomised factoral trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-82.
45. 45. Wacker WEC, Parisi AF. Magnesium metabolism. N Engl J Med 1968; 278: 658-63, 712, 772-6.
46. 46. Chesley LC, Tepper I. Some effects of magnesium loading upon renal excretion of magnesium and certain other electrolytes. J Clin Invest 1958; 37: 1362-72. Aust NZ J Med 2000; 30